Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential Expression of CD79B, CD19, and PD-L1 in de Novo and Transformed CD20-Negative Large B-Cell Lymphomas. | Hematol Oncol | 2026 | 41689301 | PubTator, text mining | PubMed |
| Targetable Vulnerabilities in MYC-Driven B Cell Lymphomas Resistant to BCR Extinction. | Hematol Oncol | 2026 | 41668618 | PubTator, text mining | PubMed |
| Meta regression of endoscopic sleeve gastroplasty versus intragastric balloon investigating influence of duration and baseline body mass index. | Sci Rep | 2026 | 41639211 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing and Bulk RNA Sequencing Revealed the Interplay Between Intratumoral Heterogeneity and the Tumor Microenvironment in Breast Cancer. | Cancer Med | 2026 | 41635010 | PubTator, text mining | PubMed |
| Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial. | Nat Commun | 2026 | 41629292 | PubTator, text mining | PubMed |
| Clonal Complexity Defines Distinct Tumor-Intrinsic Biology and Prognosis in Diffuse Large B-Cell Lymphoma. | Cancer Med | 2026 | 41629261 | PubTator, text mining | PubMed |
| CXCL12 derived from cancer-associated fibroblasts mediates dysfunctional intratumoral adaptive immunity in diabetic pancreatic adenocarcinoma. | Cell Oncol (Dordr) | 2026 | 41627726 | PubTator, text mining | PubMed |
| Potential role of 68Ga- and 177Lu-cyclic pentapeptides for in-vivo targeting CXCR4 receptor expression in chemotherapy relapse MCL patient. | Asia Ocean J Nucl Med Biol | 2026 | 41626116 | PubTator, text mining | PubMed |
| Next-generation Bruton's tyrosine kinase inhibitors for chronic lymphocytic leukemia-associated membranoproliferative glomerulonephritis: a case report. | Ann Hematol | 2026 | 41612086 | PubTator, text mining | PubMed |
| Association-induced folding governs surrogate light chain and pre-B cell receptor core assembly. | Nat Commun | 2026 | 41611721 | PubTator, text mining | PubMed |
| Gene mutation in metabolism syndrome with hematologic tumor: A retrospective cohort study. | Clin Exp Med | 2026 | 41609917 | PubTator, text mining | PubMed |
| Clonal CD8+ T cells populate the leptomeninges and coordinate with immune cells in human degenerative brain diseases. | Nat Immunol | 2026 | 41593242 | PubTator, text mining | PubMed |
| Oligoclonal B cell expansion and passenger fusion genes predict response to Nivolumab in recurrent ovarian cancer: phase II Kyoto trial. | Cancer Immunol Immunother | 2026 | 41591474 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| Scaling the manufacture of adipose tissue-derived mesenchymal stromal cells: integrated bioreactor workflows from inoculation to harvest without the need of seed train. | BMC Biotechnol | 2026 | 41572236 | PubTator, text mining | PubMed |
| CAR-T triggers TAM reeducation and adaptive anti-tumor response via TREM2 deficiency or CD40 agonist. | Cell Rep Med | 2026 | 41564864 | PubTator, text mining | PubMed |
| Biological heterogeneity in adult IRF4-rearranged large B-cell lymphoma: Stratification by age and anatomical site. | Hemasphere | 2026 | 41560848 | PubTator, text mining | PubMed |
Effectiveness and Safety of a Supplement Containing a Pharmacologically Active Basidiomycete Mushroom for Chronic Fatigue and Post-COVID-19 Fatigue Syndrome: Protocol for a Randomized Controlled Trial. | JMIR Res Protoc | 2026 | 41558017 | PubTator, text mining | PubMed |
| Marginal zone lymphoma presenting with chylous ascites: A rare clinical manifestation and successful treatment with orelabrutinib-rituximab. | SAGE Open Med Case Rep | 2026 | 41551116 | PubTator, text mining | PubMed |
| Neuro-related gene signatures predict prognosis in diffuse large B-Cell lymphoma and uncover TRPV2-mediated tumor microenvironment regulation. | Ann Hematol | 2026 | 41549103 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=5